Literature DB >> 25136786

The role of genetics and epigenetics in the pathogenesis of systemic sclerosis.

Jasper C A Broen1, Timothy R D J Radstake1, Marzia Rossato1.   

Abstract

Systemic sclerosis (SSc) is a complex autoimmune disease of unclear aetiology. A multitude of genetic studies, ranging from candidate-gene studies to genome-wide association studies, have identified a large number of genetic susceptibility factors for SSc and its clinical phenotypes, but the contribution of these factors to disease susceptibility is only modest. However, in an endeavour to explore how the environment might affect genetic susceptibility, epigenetic research into SSc is rapidly expanding. Orchestrated by environmental factors, epigenetic modifications can drive genetically predisposed individuals to develop autoimmunity, and are thought to represent the crossroads between the environment and genetics in SSc. Therefore, in addition to providing a comprehensive description of the current understanding of genetic susceptibility underlying SSc, this Review describes the involvement of epigenetic phenomena, including DNA methylation patterns, histone modifications and microRNAs, in SSc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25136786     DOI: 10.1038/nrrheum.2014.128

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  100 in total

1.  A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations.

Authors:  Lara Bossini-Castillo; Jose-Ezequiel Martin; Jasper Broen; Olga Gorlova; Carmen P Simeón; Lorenzo Beretta; Madelon C Vonk; Jose Luis Callejas; Ivan Castellví; Patricia Carreira; Francisco José García-Hernández; Mónica Fernández Castro; Marieke J H Coenen; Gabriela Riemekasten; Torsten Witte; Nicolas Hunzelmann; Alexander Kreuter; Jörg H W Distler; Bobby P Koeleman; Alexandre E Voskuyl; Annemie J Schuerwegh; Øyvind Palm; Roger Hesselstrand; Annika Nordin; Paolo Airó; Claudio Lunardi; Raffaella Scorza; Paul Shiels; Jacob M van Laar; Ariane Herrick; Jane Worthington; Christopher Denton; Filemon K Tan; Frank C Arnett; Sandeep K Agarwal; Shervin Assassi; Carmen Fonseca; Maureen D Mayes; Timothy R D J Radstake; Javier Martin
Journal:  Hum Mol Genet       Date:  2011-11-10       Impact factor: 6.150

2.  Demethylation of TNFSF7 contributes to CD70 overexpression in CD4+ T cells from patients with systemic sclerosis.

Authors:  HongYan Jiang; Rong Xiao; XiaoRi Lian; Takuro Kanekura; YangYang Luo; YongXing Yin; GuiYing Zhang; Yan Yang; YaoYao Wang; Ming Zhao; QianJin Lu
Journal:  Clin Immunol       Date:  2012-01-18       Impact factor: 3.969

3.  Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts.

Authors:  F C Arnett; M Cho; S Chatterjee; M B Aguilar; J D Reveille; M D Mayes
Journal:  Arthritis Rheum       Date:  2001-06

4.  Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis.

Authors:  Rajpreet K Arora-Singh; Shervin Assassi; Deborah J del Junco; Frank C Arnett; Marilyn Perry; Uzma Irfan; Roozbeh Sharif; Tony Mattar; Maureen D Mayes
Journal:  J Autoimmun       Date:  2010-03-11       Impact factor: 7.094

5.  HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans.

Authors:  Xiaodong Zhou; Jong Eun Lee; Frank C Arnett; Momiao Xiong; Min Young Park; Yeon Kyeong Yoo; Eun Soon Shin; John D Reveille; Maureen D Mayes; Jin Hyun Kim; Ran Song; Ji Yong Choi; Ji Ah Park; Yun Jong Lee; Eun Young Lee; Yeong Wook Song; Eun Bong Lee
Journal:  Arthritis Rheum       Date:  2009-12

6.  Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies.

Authors:  Carol Feghali-Bostwick; Thomas A Medsger; Timothy M Wright
Journal:  Arthritis Rheum       Date:  2003-07

7.  STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.

Authors:  P Dieudé; M Guedj; J Wipff; B Ruiz; E Hachulla; E Diot; B Granel; J Sibilia; K Tiev; L Mouthon; J L Cracowski; P H Carpentier; Z Amoura; I Fajardy; J Avouac; O Meyer; A Kahan; C Boileau; Y Allanore
Journal:  Arthritis Rheum       Date:  2009-08

8.  Human polymorphism at microRNAs and microRNA target sites.

Authors:  Matthew A Saunders; Han Liang; Wen-Hsiung Li
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

9.  DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis.

Authors:  Y Y Wang; Q Wang; X H Sun; R Z Liu; Y Shu; T Kanekura; J H Huang; Y P Li; J C Wang; M Zhao; Q J Lu; R Xiao
Journal:  Br J Dermatol       Date:  2014-07-06       Impact factor: 9.302

10.  Linking disease associations with regulatory information in the human genome.

Authors:  Marc A Schaub; Alan P Boyle; Anshul Kundaje; Serafim Batzoglou; Michael Snyder
Journal:  Genome Res       Date:  2012-09       Impact factor: 9.043

View more
  35 in total

1.  Life-Long Implications of Developmental Exposure to Environmental Stressors: New Perspectives.

Authors:  Philippe Grandjean; Robert Barouki; David C Bellinger; Ludwine Casteleyn; Lisa H Chadwick; Sylvaine Cordier; Ruth A Etzel; Kimberly A Gray; Eun-Hee Ha; Claudine Junien; Margaret Karagas; Toshihiro Kawamoto; B Paige Lawrence; Frederica P Perera; Gail S Prins; Alvaro Puga; Cheryl S Rosenfeld; David H Sherr; Peter D Sly; William Suk; Qi Sun; Jorma Toppari; Peter van den Hazel; Cheryl L Walker; Jerrold J Heindel
Journal:  Endocrinology       Date:  2015-08-04       Impact factor: 4.736

Review 2.  Vasculopathy in scleroderma.

Authors:  Yoshihide Asano; Shinichi Sato
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

Review 3.  Epigenetics in Kidney Transplantation: Current Evidence, Predictions, and Future Research Directions.

Authors:  Valeria R Mas; Thu H Le; Daniel G Maluf
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

Review 4.  Double heterozygous mice for Klf5 and Fli1 genes: a new animal model of systemic sclerosis recapitulating its three cardinal pathological features.

Authors:  Yoshihide Asano
Journal:  Med Mol Morphol       Date:  2015-05-19       Impact factor: 2.309

5.  Comparison of the clinical phenotype of systemic sclerosis patients in Iran and France in two university centers.

Authors:  Yannick Allanore; Farhad Gharibdoost; Ahmad Reza Jamshidi; Ali Javinani; Jérôme Avouac; Elnaz Rastkar; Sadid Hooshmandi; Hoda Kavosi
Journal:  J Scleroderma Relat Disord       Date:  2018-11-20

6.  Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis.

Authors:  Ryosuke Saigusa; Yoshihide Asano; Takashi Taniguchi; Takashi Yamashita; Yohei Ichimura; Takehiro Takahashi; Tetsuo Toyama; Ayumi Yoshizaki; Koji Sugawara; Daisuke Tsuruta; Tadatsugu Taniguchi; Shinichi Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-23       Impact factor: 11.205

Review 7.  Genetics, Epigenetics, and Genomics of Systemic Sclerosis.

Authors:  Gloria Salazar; Maureen D Mayes
Journal:  Rheum Dis Clin North Am       Date:  2015-05-20       Impact factor: 2.670

8.  Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study.

Authors:  Xue Li; Yu-Quan Qian; Na Liu; Rong Mu; Yu Zuo; Guo-Chun Wang; Yuan Jia; Zhan-Guo Li
Journal:  Clin Rheumatol       Date:  2018-09-18       Impact factor: 2.980

9.  Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures Perspectives.

Authors:  Fabian A Mendoza; Maryah Mansoor; Sergio A Jimenez
Journal:  Expert Opin Orphan Drugs       Date:  2015-11-23       Impact factor: 0.694

10.  A Novel Insight into Endothelial and Cardiac Cells Phenotype in Systemic Sclerosis Using Patient-Derived Induced Pluripotent Stem Cell.

Authors:  Sedigheh Gholami; Zahra Mazidi; Sara Pahlavan; Fariba Moslem; Mahya Hosseini; Adeleh Taei; Mahdi Hesaraki; Maryam Barekat; Nasser Aghdami; Hossein Baharvand
Journal:  Cell J       Date:  2021-07-17       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.